DUS2 and non-small cell lung carcinoma: Significantly, NSCLC cells transfected with si-hDUS2-#2 showed a decrease in dihydrouridine levels and growth inhibition, suggesting that the selective inhibition of hDUS2 might have the potential to treat NSCLC (Kato et al., 2005).